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Executive Summary Checklist

Severe hypoglycemia (SH) causes significant morbidity and occasional mortality in hospitalized
patients. The establishment of an effective program to reduce errors in the recognition and
treatment of SH requires an implementation plan that includes the following actionable steps:
¨ Establish a commitment from hospital administration and medical leadership to reduce
SH.
¨ Raise institutional awareness of the issue by comparing hospital and nursing units based
on performance quality scorecards.
¨ Create a multidisciplinary team that includes physicians, pharmacists, nurses, diabetic
educators, medication safety officers, case managers, and long-term healthcare
professionals. This team will:
¨ Develop a system to identify patients receiving anti-diabetic medications
(sulfonylureas, insulins, etc.) in the Electronic Health Record (EHR).
¨ Implement real-time surveillance methods, analysis tools, and point-of-care
blood glucose (BG) monitoring and reporting systems.
¨ Create insulin order sets that could be modified to reduce risks of
hypoglycemia.
¨ Coordinate glucose monitoring, insulin administration, and meal delivery during
changes of shift and times of patient transfer.
¨ Develop a systematic approach to reduce SH and implement universal best
practices.
¨ Continuously monitor the incidence of SH in the hospital, and use the results of this
monitoring in medical staff education sessions as a part of Continuous Quality
Improvement (CQI).
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The Performance Gap
Hypoglycemia is a common problem for many patients with diabetes. Mild episodes can cause
unpleasant symptoms and disrupt daily activities. Severe hypoglycemia (SH) can result in disorientation
and unusual behavior, and may be life-threatening. Frequent hypoglycemia is associated with increased
morbidity, length of stay, and mortality. Hypoglycemia has been associated with mortality in the
intensive care units.1 Moderate and SH are strongly associated with increased risk of death, especially
from distributive shock.2 This is by means of impairment of autonomic function, alteration of blood flow
and composition, white cell activation, vasoconstriction, and the release of inflammatory mediators and
cytokines.3,4
The prevalence of hypoglycemia (<70 mg/dL) was reported as 5.7% of all point-of-care blood glucose
(BG) tests in a 2009 survey of 575 hospitals.5 The definition of SH (a low BG level that requires the
assistance of another person for recovery), is a level <40 mg/dL, has been adopted as the level likely to
cause harm in the hospital setting.6 SH is a preventable harm. Early therapeutic management of mild
hypoglycemia can prevent more SH episodes. In addition, literature showed that clinicians do not
consistently adjust their patient’s anti-diabetic regimens appropriately following treatment of
hypoglycemia, placing the patient at additional risk.7,8
Causative factors that may lead to the development of hypoglycemia for inpatients may include
excessive insulin dose, inappropriate timing of insulin or anti-diabetes therapy, unaddressed antecedent
hypoglycemia or changes in the nutritional regimen, creatinine clearance changes, or steroid dose (9).9
Failure of effective BG monitoring and communication between physicians, pharmacists and nurses can
also contribute to the problem. The diverse nature of potential errors in the treatment of inpatients with
SH supports the need for a decision-making model that can be used to predict and prevent SH episodes
and improve overall patient safety and outcomes.
Closing the performance gap will require hospitals and healthcare systems to commit to action in the
form of specific leadership, practice, and technology plans.

1

Elliot M, Schafers S, McGill J, et al. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci

Technol 2012;6(2):302-309.
2

The NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012;367:1108-

1118.
3

Adler GK, Bonyhay I, Failing H, et al. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for

rigorous glycemic control. Diabetes 2009;58:360-366.
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Wrogjt RJ, Frier BM. Vascular disease and diabetes: is hypoglycemia an aggravating factor? Diabetes Metab Res Rev

2008;24:353-363.
5

Swanson CM, Potter DJ, Kongable GL, et al. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract

2011;17(6):853-861.
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Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Diabetes-related complications, glycemic control, and falls in older adults.

Diabetes Care 2008;31(3):391-396.
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Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J

Med 2011;124(11):1028-1035.
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DiNardo M, Noschese M, Korytkowski M, et al. The medical emergency team and rapid response system; finding, treating, and
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Deal EN, Liu A, Wise LL, et al. Inpatient insulin orders: Are patients getting what is prescribed? J Hosp Med 2011;6(9):526-529.
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Leadership Plan
•
•
•
•
•
•

The plan must include the fundamentals of change outlined in the National Quality Forum safe
practices, including awareness, accountability, ability, and action.10
Hospital governance and senior administrative leadership (medical, pharmacy, and nursing) must
fully understand the performance gaps in their own healthcare system.
Hospital governance, senior administrative leadership, and clinical/safety leadership must close
their own performance gaps by implementing a comprehensive approach.
Hospitals should set a goal date for the implementation of the corrective plan, with measurable
quality indicators and milestones.
Specific budget allocations for the plan should be evaluated by governance boards and senior
administrative leaders.
Clinical/safety leadership should endorse the plan and ensure implementation across all
providers and systems.

Practice Plan
•

•

•

•

10

Each hospital should create a multidisciplinary team, which includes physicians, pharmacists,
nurses, diabetic educators, medication safety officers, case managers, and long-term healthcare
professionals).
Develop a systematic approach to reducing severe hypoglycemia:
o Identify events and prioritize
o Raise institutional awareness
§ Compare hospitals and nursing units based on performance quality scorecards
(use harm rate for at-risk patient days: # of events/# of patient days during
hospital stay when a diabetic agent is ordered at any time)
o Encourage nurses to enter hypoglycemia into safety event self-reporting site
o Communicate to the hospital leadership board
o Send letters to physicians and providers (from case managers)
o Educate hospital staff, providers and patients – hospital newsletter and posters made for
each hospital/nursing unit listing known and assumed solutions to hypoglycemia (e.g.,
“STOP Hypoglycemia!”)
o Kickoff reception for safety initiative
Implement foundational Best Practices and “Just Do Its” (Appendices A and B)
o Establish a Hypoglycemia Task Force for the hospital
o Propose multidisciplinary diabetes safety team at each hospital
o Adopt foundational best practices (literature-based recommendations for all hospitals)
o Implement “Just Do Its!” (or “Start Nows”) – these should be safe and reasonable
interventions tested internally
o Adopt ISMP recommendations for U-500 insulin precautions (Appendix C)
Event investigation and collect causative factors
o Causative Factors (to consider as part of analysis tool):
§ Insulin stacking
§ Wrong drug, dose, route, patient, or time
§ Insufficient glucose monitoring
§ Basal heavy regimen

NQF Safe Practices for Healthcare. 2010 Update.
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•

§ Decreased nutritional intake
§ Event related to outpatient or emergency department drug administration
§ Event while treating elevated potassium
§ Glucose trend not recognized
§ High dose sliding scale insulin
§ Home regimen continued as inpatient
§ Significant reduction in steroid dose
§ Sulfonylurea-related hypoglycemia
§ Insulin administration and food intake not synchronized
§ POC glucose reading not linked to insulin administration
§ POC glucose reading not synchronized with food intake
o Analysis tool forms reviewed by either pharmacist and/or nurse in a timely manner (e.g.,
72 hours) for causative factors; communicate findings with physician(s)
o Results are collated and reported to Medication Safety Committee and the Pharmacy
and Therapeutics Committee
o Identify interventions (evidence-based and expert opinion) that are used to resolve the
most common or most harmful causative factors
o Track the interventions and create customized action plans based on an integrated
results dashboard
o Share best practices within hospital and to other hospitals
Share strategies and implement informed interventions on target floors and patients.

Technology Plan
Suggested practices and technologies are limited to those proven to show benefit or are the only known
technologies with a particular capability. As other options may exist, please send information on any
additional technologies, along with appropriate evidence, to info@patientsafetysummit.org.
•
•
•

•
•
•

Implement real-time surveillance method for informatics alerts: “High-Risk Sulfonylurea Alert”
and “Hypoglycemia Risk Alert”.
Implement an automated hypoglycemia event analysis tool (to discover local causes of
hypoglycemia and guide future interventions).
Implement point-of-care BG monitoring and reporting systems, including quality assurance
reports to audit compliance with hypoglycemia management goals and restriction of insulin
utilization.
Implement automated triggers for most common causative factors of hypoglycemia, an
electronic tracking system for SH events, interventions used and clinical outcomes.
Implement a results dashboard for each nursing unit within the hospital and Best Practices used
to resolve the hypoglycemic event(s).
Set restrictions for the prescribing of U-500 Regular Insulin to only specialists and under special
circumstances in CPOE.
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System or Practice

Available Technology

ONC Meaningful Use Certified EHR system Electronic
Health Record (EHR) System with the following
capabilities:
• Computerized Physician Order Entry (CPOE)
• Drug-drug interaction check
• Drug-allergy interaction check
• Clinical Decision Support tools (CDS)

The following EHR vendors have signed
the Patient Safety Movement Open Data
Pledge:11
• Cerner
• GE Healthcare

CPOE simulation tool to quantify the risk of serious ADEs
with your current system CPOE12,13

•

Leapfrog CPOE Evaluation
Tool14

Drug Libraries

•
•
•
•
•
•

Alaris®
Baxter®
Hospira®
Fresenius®
B.Braun® I.V. pumps
BD Intelliport™ Medication
Management System for I.V.
injectables, or
comparable systems.

•
Pharmacy Workflow Manager

•

DoseEdge® from Baxter
Healthcare®

Workgroup
Chair:
OPEN
Co-Leaders:
Ron Jordan, RPh, FAPhA, Dean, Chapman University School of Pharmacy
Jerika Lam, PharmD, AAHIVP, FCSHP, Assistant Professor, Chapman University School of Pharmacy
11

12

EHR companies that have signed Patient Safety Movement Open Data Pledge
Leung AA, Keohane C, Lipsitz S, Zimlichman E, Amato M, Simon SR, Coffey M, Kaufman N, Cadet B, Schiff G, Seger DL, Bates

DW. Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med
Inform Assoc. 2013 Jun;20(e1):e85-90.
13

Metzger J, Welebob E, Bates DW, Lipsitz S, Classen DC. Mixed results in the safety performance of computerized physician

order entry. Health Aff (Millwood). 2010 Apr;29(4):655-63.
14

https://leapfroghospitalsurvey.org/cpoe-evaluation-tool/
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Appendix A: Summary of Foundational Best Practices15
Intervention
Elevate awareness of hypoglycemia

Real time analysis (48 hours)

Create and utilize diabetes
management team

Provide prescriber with tools to use
as a dosing guide

Nursing education process

Insulin dose timing coincide with
food intake

Improve POC glucose testing with
the insulin administration time

Utilize glucose management
software

15

Rationale
Best in class and individual hospital initiatives to elevate
awareness on preventable harm have improved patient care.
Pharmacy surveillance system provides information of when and
where these events occur, but not why they occur. Many hospitals
have had success lowering harm rate using this intervention.
AACE/ADA (American Association of Clinical
Endocrinologists/American Diabetes Association) noted creation
of a multidisciplinary steering committee guided by local diabetic
experts can establish reasonable and achievable glycemic
management goals.
• AACE/ADA suggests a systems approach for management of
inpatient glycemic control.
• Can establish reasonable and achievable glycemic
management goals with use of protocols and order sets.
• AACE/ADA noted a lack of ownership in diabetes care may be
due in part to insufficient knowledge or confidence in
diabetes management.
• Improvements in care can be achieved by ongoing education
and training.

AACE/ADA noted many hospitals are challenged by poor
coordination of meal delivery and prandial insulin
administration.
• A systems approach can promote the coordination of glucose
monitoring, insulin administration, and meal delivery,
particularly during change of shifts and times of patient
transfer.
• AACE/ADA stated that bedside BG monitoring with use of
POC glucose meters should be performed before meals and
at bedtime in most inpatients who are eating usual meals.
• Important to avoid routine use of correction insulin at
bedtime.
Collective evidence showed a reduction in hypoglycemic events
through the use of glucose software management
•

Moghissi ES, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement

on Inpatient Glycemic Control. Diabetes Care 2009;32(6):1119-1131.
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Appendix B: Just Do Its! Recommendations16

Just Do It!

Modify insulin order set to hold insulin only with MD order
Modify insulin order set to match pending electronic order set to reduce doses of
bedtime sliding scale (30% reduction)
Modify insulin order set to avoid routine correction insulin at specific times (e.g.,
0200 and 0400)
Modify insulin order set to match pending electronic order set to state: Notify MD
when hypoglycemic event occurs (2 levels <70 mg/dL or 1 level <50 mg/dL, or
>300 mg/dL)
Add Pharmacist and Endocrinologist on diabetes management team

Appendix C: Start Now: U-500 Regular Insulin Project16
Scope: Develop guidelines for injectable U-500 insulin to reduce ADE preventable harm. U-500 insulin is
an uncommon concentration, which if given with syringes designed for U-100 insulin can cause serious
harm.
Preventable Harm: Risk potential and risk severity are both high
Resources: Pharmacist(s) and nurse(s)
Deliverable Goals:
• Develop standard High Alert or High Hazard Medication or restrictions for U-500 insulin at all
hospitals to prevent improper dosing and harm secondary to hypoglycemia.
• Develop policy that will safeguard or restrict the use of U-500 to specialists and special
circumstances
Risks/Barriers:
• Hospitals that do not have the drug on formulary have not addressed patients using drug from
home;
• Hospitals feel drug not on formulary will protect them from ADEs (Non-formulary does not equal
no-risk of ADE)

16

Milligan P, Blackburn C, Dachroeden R. Multi-faceted improvement initiative to detect and improve prevention of severe

hypoglycemia. ASHP Summer Meeting 2014.
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